TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 295 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q4 2021. The put-call ratio across all filers is 0.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,223,804 | +34.3% | 143,732 | +36.4% | 0.00% | 0.0% |
Q2 2023 | $1,655,682 | -1.1% | 105,401 | +3.8% | 0.00% | 0.0% |
Q1 2023 | $1,674,228 | +9.8% | 101,559 | +4.0% | 0.00% | 0.0% |
Q4 2022 | $1,524,178 | +24.5% | 97,608 | +3.5% | 0.00% | 0.0% |
Q3 2022 | $1,224,000 | -16.3% | 94,352 | -9.5% | 0.00% | 0.0% |
Q2 2022 | $1,463,000 | -24.3% | 104,274 | +5.7% | 0.00% | -25.0% |
Q1 2022 | $1,933,000 | +38.7% | 98,617 | -3.5% | 0.00% | +33.3% |
Q4 2021 | $1,394,000 | -28.7% | 102,170 | -14.2% | 0.00% | -25.0% |
Q3 2021 | $1,956,000 | -7.9% | 119,102 | -5.6% | 0.00% | -20.0% |
Q2 2021 | $2,123,000 | +9.0% | 126,112 | +18.3% | 0.01% | 0.0% |
Q1 2021 | $1,948,000 | +14.5% | 106,594 | +13.8% | 0.01% | 0.0% |
Q4 2020 | $1,702,000 | +18.9% | 93,688 | +16.6% | 0.01% | +25.0% |
Q3 2020 | $1,432,000 | +16.2% | 80,374 | +16.9% | 0.00% | 0.0% |
Q2 2020 | $1,232,000 | +20.5% | 68,740 | +2.9% | 0.00% | 0.0% |
Q1 2020 | $1,022,000 | – | 66,817 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Adelphi Capital LLP | 8,958,784 | $176,757,000 | 33.75% |
Ovata Capital Management Ltd | 879,800 | $17,557,092,000 | 13.04% |
Paulson & Co. | 13,244,711 | $261,318,000 | 5.64% |
Glenview Capital Management | 30,582,721 | $603,397,000 | 5.28% |
MIC CAPITAL PARTNERS (PUBLIC) (US) IM, LLC | 718,028 | $14,167,000 | 4.85% |
Velanne Asset Management Ltd | 302,694 | $5,972,000 | 3.52% |
Blackcrane Capital, LLC | 172,708 | $3,408,000 | 2.72% |
Melqart Asset Management (UK) Ltd | 1,557,000 | $30,720,000 | 2.57% |
GMT CAPITAL CORP | 3,345,976 | $66,016,000 | 2.55% |
REDWOOD CAPITAL MANAGEMENT, LLC | 827,955 | $16,336,000 | 2.24% |